Work

A Phase I and Pharmacologic Study of Pyrazoloacridine (NSC 366140) and Carboplatin in Patients with Advanced Cancer

Year: 2002

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1016237426846

Authors: Alex A. Adjei, Joel M. Reid, Charles Erlichman, Jeff A. Sloan, Henry C. Pitot, Steven R. Alberts, Richard M. Goldberg, Lorelei J. Hanson, Stacie Ruben, Scott A. Boerner, Pamela Atherton, Matthew M. Ames, Scott H. Kaufmann

Institution: Mayo Clinic

Language: English

Topic: Metal complexes synthesis and properties

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources, NIH Clinical Center

Awards: CLINICAL STUDIES OF SIGNAL TRANSDUCTION INHIBITORS, G2424197942, G27062282, G447447039, G5087919879, General Clinical Research Center, G6314433561, G932523968

OpenAlex ID: W153301735

FWCI: 0.274

Cites: 20

Cited by: 6

Related to: 10